Literature DB >> 12007549

Predictors of nursing home admission and/or death in incident Alzheimer's disease and other dementia cases compared to controls: a population-based study.

Elaine D Eaker1, Robert A Vierkant, Susan F Mickel.   

Abstract

This research elucidates the risk of institutional care and/or death of patients with Alzheimer's disease (AD) or other dementia (OD) compared with noncases. Community dwelling incident cases of AD (n = 240) or OD (n = 208) and age-matched noncases (n = 363) living in an enumerated population were included. The adjusted hazard ratio (HR) of being admitted to a nursing home compared with controls was 5.44 (95% confidence interval, CI: 3.68,8.05) for AD cases and 5.08 (95% CI: 3.38, 7.63) for OD cases. The adjusted RR of death compared to controls was 1.90 (95% CI: 1.36, 2.65) for AD cases and 2.27 (95% CI: 1.62, 3.18) for OD cases. This is the only population-based study in the U.S. documenting that AD/OD increases the risk of death independent of comorbid conditions. AD/OD patients have more comorbidities and are at greater risk of entering a nursing home than to die during the follow-up, compared with those without these diagnoses.

Entities:  

Mesh:

Year:  2002        PMID: 12007549     DOI: 10.1016/s0895-4356(01)00498-x

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  22 in total

1.  Baseline differences and trajectories of change for deceased, placed, and community residing Alzheimer disease patients.

Authors:  Richard Schulz; Bozena Zdaniuk; Steven H Belle; Sara J Czaja; Henry Michael Arrighi; Arthur S Zbrozek
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Apr-Jun       Impact factor: 2.703

2.  Use of antipsychotics among elderly nursing home residents with dementia in the US: an analysis of National Survey Data.

Authors:  Pravin Kamble; Hua Chen; Jeffrey T Sherer; Rajender R Aparasu
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

Review 3.  The coming crisis: obtaining care for the growing burden of neurodegenerative conditions.

Authors:  E Ray Dorsey; Benjamin P George; Bruce Leff; Allison W Willis
Journal:  Neurology       Date:  2013-04-24       Impact factor: 9.910

4.  Drivers of Long-Term Care Considerations by Persons With Cognitive Impairment.

Authors:  Megan Shepherd-Banigan; Hailey J James; Valerie A Smith; Brenda L Plassman; Eric Jutkowitz; Emmanuelle Belanger; Courtney H Van Houtven
Journal:  J Appl Gerontol       Date:  2020-02-06

5.  Institutionalization in incident dementia cases in comparison to age- and sex- matched controls: a 5-year follow-up from Germany.

Authors:  Jana Schulze; Hendrik van den Bussche; Hanna Kaduszkiewicz; Daniela Koller; Falk Hoffmann
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-06-08       Impact factor: 4.328

6.  Impact of rivastigmine use on the risk of nursing home placement in a US sample.

Authors:  Kathleen M Beusterien; Simu K Thomas; Douglas Gause; Miriam Kimel; Stephen Arcona; Dario Mirski
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

7.  Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease.

Authors:  O L Lopez; J T Becker; A S Wahed; J Saxton; R A Sweet; D A Wolk; W Klunk; S T Dekosky
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-02-09       Impact factor: 10.154

8.  Comorbidity in dementia: update of an ongoing autopsy study.

Authors:  Shino Magaki; William H Yong; Negar Khanlou; Spencer Tung; Harry V Vinters
Journal:  J Am Geriatr Soc       Date:  2014-07-15       Impact factor: 5.562

9.  Dementia as a determinant of social and health service use in the last two years of life 1996-2003.

Authors:  Leena Forma; Pekka Rissanen; Mari Aaltonen; Jani Raitanen; Marja Jylhä
Journal:  BMC Geriatr       Date:  2011-04-06       Impact factor: 3.921

10.  Determinants of technology adoption and continued use among cognitively impaired older adults: a qualitative study.

Authors:  Samantha Dequanter; Maaike Fobelets; Iris Steenhout; Marie-Pierre Gagnon; Anne Bourbonnais; Samira Rahimi; Ronald Buyl; Ellen Gorus
Journal:  BMC Geriatr       Date:  2022-04-28       Impact factor: 4.070

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.